Citation Impact
Citing Papers
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
2008 Standout
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
2020 Standout
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
2018 Standout
Mycobacterium tuberculosis Triggers Host Type I IFN Signaling To Regulate IL-1β Production in Human Macrophages
2011
Switch from Efavirenz to Nevirapine Associated with Resolution of Efavirenz-Related Neuropsychiatric Adverse Events and Improvement in Lipid Profiles
2006
Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: A Single Center Study of Epidemiologic Migration-Specific and Clinical Features
2004
A Ten-Year Analysis of the Incidence and Risk Factors for Acute Pancreatitis Requiring Hospitalization in an Urban HIV Clinical Cohort
2008
No health without mental health
2007 Standout
Early Versus Delayed Antiretroviral Therapy and Cerebrospinal Fluid Fungal Clearance in Adults With HIV and Cryptococcal Meningitis
2013 StandoutNobel
Adverse effects of antiretroviral therapy for HIV infection: a review of selected topics
2005
Persistent immune activation in chronic HIV infection
2013
A new lipid emulsion formulation with high antimicrobial efficacy using chitosan
2002
Innate IL-17-producing cells: the sentinels of the immune system
2010 Standout
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Leishmaniasis
2018 Standout
GROWTH SUPPRESSION BY GLUCOCORTICOID THERAPY
1996
Stratification and compartmentalisation of immunoglobulin responses to commensal intestinal microbes
2013
The use of prophylactic antibiotics in head and neck oncological surgery
2006
Human Immunodeficiency Virus/Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome: Clinical Presentation, Pathophysiology, and Therapeutic Strategies
2003
High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients
2008
Fluoroquinolone-Resistant Campylobacter Isolates from Conventional and Antibiotic-Free Chicken Products
2005
Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia
2009
The World report on ageing and health: a policy framework for healthy ageing
2015 Standout
Neutrophils at work
2014 Standout
T cell exhaustion
2011 Standout
The metabolic syndrome
2010 Standout
Inflammatory Co-morbidities in HIV+ Individuals: Learning Lessons from Healthy Ageing
2014
A Randomized Study of the Use of Fluconazole in Continuous versus Episodic Therapy in Patients with Advanced HIV Infection and a History of Oropharyngeal Candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40
2005
Adipocytes as regulators of energy balance and glucose homeostasis
2006 StandoutNature
Type I interferons in infectious disease
2015 Standout
The X-ray crystal structure of phosphomannose isomerase from Candida albicans at 1.7 Å resolution
1996
HLA-B*5701 Screening for Hypersensitivity to Abacavir
2008 Standout
Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions
2010
Telomerase Antagonists GRN163 and GRN163L Inhibit Tumor Growth and Increase Chemosensitivity of Human Hepatoma *
2005
Treatment of Meningitis Caused by Methicillin-Resistant Staphylococcus aureus with Linezolid
2007
Major but differential decline in the incidence of Staphylococcus aureus bacteraemia in HIV‐infected individuals from 1995 to 2007: a nationwide cohort study*
2011
Inhibition of the type I immune responses of human monocytes by IFN-α and IFN-β
2013
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Complete genomic sequences for hepatitis C virus subtypes 6e and 6g isolated from Chinese patients with injection drug use and HIV-1 co-infection
2006
Association of tenofovir exposure with kidney disease risk in HIV infection
2012
The metabolic syndrome
2005 Standout
PKDL and Other Dermal Lesions in HIV Co-infected Patients with Leishmaniasis: Review of Clinical Presentation in Relation to Immune Responses
2014
Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting
2011
Staphylococcus aureus Meningitis
2010
The biofilm matrix
2010 Standout
Effect of linezolid against postneurosurgical meningitis caused by methicillin-resistant Staphylococcus epidermidis: case report
2008
Lipodystrophies: rare disorders causing metabolic syndrome
2004
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource
2013 StandoutNobel
Three- vs Four-Drug Antiretroviral Regimens for the Initial Treatment of HIV-1 Infection<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2006
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Asthma
2001 Standout
Management of the metabolic effects of HIV and HIV drugs
2011
Antibiotic use in dermatologic surgery
2003
The Role of Topical Antibiotic Prophylaxis in Patients Undergoing Contaminated Head and Neck Surgery With Flap Reconstruction
2001
IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice
2010
Unique features revealed by the genome sequence of Acinetobacter sp. ADP1, a versatile and naturally transformation competent bacterium
2004
The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease
2011 Standout
Hypoxia-inducible Factor (HIF) Asparagine Hydroxylase Is Identical to Factor Inhibiting HIF (FIH) and Is Related to the Cupin Structural Family
2002 StandoutNobel
IL-10, T cell exhaustion and viral persistence
2007
Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France
2005
Multivariate analysis of risk factors for wound infection in head and neck squamous cell carcinoma surgery with opening of mucosa. Study of 260 surgical procedures
2005
Prognostic significance of wound infections following major head and neck cancer surgery: an open non-comparative prospective study
2004
Hypertriglyceridemia: its etiology, effects and treatment
2007
Comparison of the Early Fungicidal Activity of High-Dose Fluconazole, Voriconazole, and Flucytosine as Second-Line Drugs Given in Combination With Amphotericin B for the Treatment of HIV-Associated Cryptococcal Meningitis
2011
A Study of Sexuality and Health among Older Adults in the United States
2007 Standout
Inhibition of HIV replication: A powerful antiviral strategy by IFN-β gene delivery in CD4+ cells
2007 StandoutNobel
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Association of influenza virus infection and inflammatory cytokines with acute myocardial infarction
2012
Immune Reconstitution Inflammatory Syndrome in HIV-Associated Cryptococcal Meningitis: A Prospective Study
2009
HIV infection and cardiovascular disease
2014
Adipose Tissue as an Endocrine Organ
2004 Standout
Lipodystrophy: lessons in lipid and energy metabolism
2006
Infections and SLE
2005
Practice Guidelines for Diseases Caused by Aspergillus
2000
Older Women's Attitudes, Behavior, and Communication about Sex and HIV: A Community-Based Study
2006
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV
2008
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Highly Enantioselective Hydrogenation of Ethyl 5,5‐Dimethoxy‐3‐oxopentanoate and its Application for the Synthesis of a Statin Precursor
2008
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Gut Microbiota in Health and Disease
2010 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Plasma Levels, Safety, and 60-Week Efficacy of a Once-Daily Double-Boosted Protease Inhibitor Regimen of Atazanavir, Saquinavir, and Ritonavir
2008
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
The immunomodulatory Pseudomonas aeruginosa signalling molecule N‐(3‐oxododecanoyl)‐l ‐homoserine lactone enters mammalian cells in an unregulated fashion
2007
Global trends in antimicrobial use in food animals
2015 Standout
Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort Study
2015
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Chemicals from lignin: an interplay of lignocellulose fractionation, depolymerisation, and upgrading
2018 Standout
Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
2019 Standout
Pharmacokinetics and Pharmacodynamics of Combined use of Lopinavir/Ritonavir and Rosuvastatin in HIV-Infected Patients
2007
Chitosan—A versatile semi-synthetic polymer in biomedical applications
2011 Standout
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Introduction to the human gut microbiota
2017 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Antiretroviral drugs and liver injury
2008
Primary Care Guidelines for the Management of Persons Infected with Human Immunodeficiency Virus: 2009 Update by the HIV Medicine Association of the Infectious Diseases Society of America
2009
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
DNA Binding: a Novel Function of Pseudomonas aeruginosa Type IV Pili
2005
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
2012 Standout
The Relationship between Leishmaniasis and AIDS: the Second 10 Years
2008
Origins and Evolution of Antibiotic Resistance
2010 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Neuropsychiatric manifestations of HIV infection and AIDS
2005
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of Roberto Manfredi being referenced
Case‐Control Study of Amphotericin B in a Triglyceride Fat Emulsion versus Conventional Amphotericin B in Patients with AIDS
1998
Voriconazole Proves Effective in Long-Term Treatment of a Cerebral Cryptococcoma in a Chronic Nephropathic HIV-Negative Patient, after Fluconazole Failure
2004
Reactivation of severe, acute pulmonary tuberculosis during treatment with pegylated interferon-alpha and ribavirin for chronic HCV hepatitis
2006
Substitution of nevirapine or efavirenz for protease inhibitor versus lipid-lowering therapy for the management of dyslipidaemia
2005
Primary lymph node invasive aspergillosis
1996
HIV disease among immigrants coming to Italy from outside of the European Union: a case-control study of epidemiological and clinical features
2001
Long-term statin use does not act on the temporal trend of CD4 cell count in patients on virologically effective HAART
2006
Stenotrophomonas (Xanthomonas) maltophilia as an Emerging Opportunistic Pathogen in Association with HIV Infection: A 10-Year Surveillance Study
2003
Growth Hormone (GH) and the Immune System: Impaired Phagocytic Function in Children with Idiopathic GH Deficiency is Corrected by Treatment with Biosynthetic GH
1994
Pseudomonas spp. complications in patients with HIV disease: An eight-year clinical and microbiological survey
2000
HIV Disease and Advanced Age
2002
Statins and fibrates for the treatment of hyperlipidaemia in HIV-infected patients receiving HAART
2003
Tenofovir-induced renal toxicity in 324 HIV-infected, antiretroviral-naïve patients
2011
Rosuvastatin for the treatment of hyperlipidaemia in HIV-infected patients receiving protease inhibitors: a pilot study
2005
Epidemiology and microbiology of cellulitis and bacterial soft tissue infection during HIV disease: a 10‐year survey
2002
Pentamidine Isethionate as Treatment and Secondary Prophylaxis for Disseminated Cutaneous Leishmaniasis During HIV Infection: Case Report
2001
The changing face of AIDS-related opportunism: Cryptococcosis in the highly active antiretroviral therapy (HAART) era. Case reports and literature review
2000
AIDS-associated Cryptococcus infection before and after the highly active antiretroviral therapy era: emerging management problems
2003
Use of Fibrates in the Management of Hyperlipidemia in HIV-Infected Patients Receiving HAART
2002
First-line efavirenz versus lopinavir–ritonavir-based highly active antiretroviral therapy for naïve patients
2004
Disseminated cutaneous leishmaniasis after visceral disease in a patient with AIDS
2004
Human Immunodeficiency Virus andHepatitis C Virus Coinfection: Epidemiology, Natural History,Therapeutic Options and Clinical Management
2004
Efavirenz Versus Nevirapine in Current Clinical Practice: A Prospective, Open-Label Observational Study
2004
Hyperlipidaemia in patients with HIV-1 infection receiving highly active antiretroviral therapy: epidemiology, pathogenesis, clinical course and management
2003
Chron's Disease, Rare Association with Selective IgA Immunodeficiency, and Development of Life-threatening Bacterial Infections
2004
Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy
2008
Nevirapine versus efavirenz in 742 patients: no link of liver toxicity with female sex, and a baseline CD4 cell count greater than 250 cells/μl
2006
<i>Acinetobacter</i> Infections in Patients with Human Immunodeficiency Virus Infection: Microbiological and Clinical Epidemiology
2000
Short-term versus long-term antimicrobial prophylaxis in oncologic head and neck surgery
1996
Clindamycin/Cefonicid in Head and Neck Oncologic Surgery: One-Day Prophylaxis Is as Effective as a Three-Day Schedule
1995
Statin Therapy Decreases Serum Levels of High-Sensitivity C-Reactive Protein and Tumor Necrosis Factor-α in HIV-Infected Patients Treated With Ritonavir-Boosted Protease Inhibitors
2012
Myocardial infarction risk in HIV-infected patients: epidemiology, pathogenesis, and clinical management
2010
Sepsis-bacteraemia and other infections due to non-opportunistic bacterial pathogens in a consecutive series of 788 patients hospitalized for HIV infection.
1993
[The incidence, etiology and clinical significance of visceral mycoses in patients with AIDS].
1993
Fatal Campylobacter jejuni bacteraemia in patients with AIDS
1999
Systemic and discoid lupus erythematosus in HIV-infected patients treated with highly active antiretroviral therapy
2003
Linezolid in the treatment of severe central nervous system infections resistant to recommended antimicrobial compounds.
2005
A case-control study of HIV-associated pancreatic abnormalities during HAART era. Focus on emerging risk factors and specific management.
2004
Fluconazole as Prophylaxis Against Fungal Infection in Patients With Advanced HIV Infection
1997
Development of Acute Psychotic Disorders and HIV-1 Infection
2000
Community-Acquired Pneumonia and Sepsis Caused by a Multiresistant Staphylococcus Aureus Strain Resulting in a Severe and Long-Lasting Multiple Organ Inflammatory Involvement
2006